As of Oct 20
| +0.036 / +13.19%|
The 2 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 1.50, with a high estimate of 2.00 and a low estimate of 1.00. The median estimate represents a +385.44% increase from the last price of 0.31.
The current consensus among 3 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.